SG Americas Securities LLC raised its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Rating) by 75.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 75,948 shares of the real estate investment trust’s stock after acquiring an additional 32,576 shares during the quarter. SG Americas Securities LLC’s holdings in Sabra Health Care REIT were worth $944,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Accel Wealth Management bought a new stake in Sabra Health Care REIT during the fourth quarter valued at about $25,000. EverSource Wealth Advisors LLC bought a new stake in shares of Sabra Health Care REIT in the 3rd quarter valued at about $29,000. Point72 Hong Kong Ltd purchased a new position in shares of Sabra Health Care REIT in the 2nd quarter worth approximately $31,000. Worth Asset Management LLC purchased a new position in shares of Sabra Health Care REIT in the 1st quarter worth approximately $44,000. Finally, Wipfli Financial Advisors LLC purchased a new stake in Sabra Health Care REIT during the third quarter valued at approximately $90,000. Institutional investors own 87.20% of the company’s stock.
Analyst Ratings Changes
Several equities analysts have issued reports on the stock. Credit Suisse Group reaffirmed a “neutral” rating and issued a $13.00 price target on shares of Sabra Health Care REIT in a report on Wednesday, April 12th. StockNews.com assumed coverage on Sabra Health Care REIT in a research note on Thursday, March 16th. They issued a “hold” rating for the company. Wells Fargo & Company started coverage on Sabra Health Care REIT in a research note on Wednesday, April 19th. They set an “underweight” rating and a $11.00 price target on the stock. Barclays decreased their price objective on shares of Sabra Health Care REIT from $15.00 to $13.00 in a research report on Tuesday. Finally, Citigroup lowered their target price on shares of Sabra Health Care REIT from $13.00 to $10.50 and set a “neutral” rating for the company in a research note on Tuesday, March 28th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $13.10.
Sabra Health Care REIT Stock Up 0.9 %
Sabra Health Care REIT Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, February 28th. Shareholders of record on Monday, February 13th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 10.53%. The ex-dividend date of this dividend was Friday, February 10th. Sabra Health Care REIT’s payout ratio is -352.93%.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.
Featured Stories
- Get a free copy of the StockNews.com research report on Sabra Health Care REIT (SBRA)
- How to Invest in the Top Grocery Stocks for This Year
- Array Technologies Brings Solar Flare To 2023 Earnings Forecast
- Best Bank Stocks to Invest in Ahead of Rising Interest Rates
- How to Invest in Farmland: 7 Simple Ways
- ExxonMobil Gushes To New Highs
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.
